{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T19:40:24Z","timestamp":1732822824924,"version":"3.30.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,28]]},"DOI":"10.7759\/cureus.74685","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T18:58:06Z","timestamp":1732820286000},"source":"Crossref","is-referenced-by-count":0,"title":["New-Onset Multiple Sclerosis in Pregnancy: Diagnostic Approaches and Treatment Dilemmas"],"prefix":"10.7759","author":[{"given":"Nathallie","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cledervern","family":"Brebnor Des Isles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazal","family":"Tannous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Saving Lives, Improving Mothers' Care 2024 - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2020-22. ( 2024). Accessed. October 19, 2024: https:\/\/www.npeu.ox.ac.uk\/mbrrace-uk\/reports\/maternal-reports\/maternal-report-2020-2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-991124","article-title":"Physiological adaptations of pregnancy affecting the nervous system","volume":"27","author":"Lee LK","year":"2007","unstructured":"Lee LK. Physiological adaptations of pregnancy affecting the nervous system. Semin Neurol. 2007, 27:405-10. 10.1055\/s-2007-991124","journal-title":"Semin Neurol"},{"key":"ref3","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi N","year":"2017","unstructured":"Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017, 19:1-10.","journal-title":"Cell J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000737","article-title":"Phases and phenotypes of multiple sclerosis","volume":"25","author":"Kantarci OH","year":"2019","unstructured":"Kantarci OH. Phases and phenotypes of multiple sclerosis. Continuum (Minneap Minn). 2019, 25:636-54. 10.1212\/CON.0000000000000737","journal-title":"Continuum (Minneap Minn)"},{"key":"ref5","article-title":"Clinically isolated syndromes: clinical characteristics, differential diagnosis, and management","volume":"52","author":"Efendi H","year":"2015","unstructured":"Efendi H. Clinically isolated syndromes: clinical characteristics, differential diagnosis, and management. Noro Psikiyatr Ars. 2015, 52:S1-S11.","journal-title":"Noro Psikiyatr Ars"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241245306","article-title":"Radiologically isolated syndrome in the spectrum of multiple sclerosis","volume":"30","author":"Okuda DT","year":"2024","unstructured":"Okuda DT, Lebrun-Fr\u00e9nay C. Radiologically isolated syndrome in the spectrum of multiple sclerosis. Mult Scler. 2024, 30:630-6. 10.1177\/13524585241245306","journal-title":"Mult Scler"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller D","year":"2005","unstructured":"Miller D,\u00a0Barkhof F,\u00a0Montalban F, et al.. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005, 4:281-8. 10.1016\/S1474-4422(05)70071-5","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/JMAU.JMAU_59_18","article-title":"Factors involved in relapse of multiple sclerosis","volume":"7","author":"Kamel FO","year":"2019","unstructured":"Kamel FO. Factors involved in relapse of multiple sclerosis. J Microsc Ultrastruct. 2019, 7:103-8. 10.4103\/JMAU.JMAU_59_18","journal-title":"J Microsc Ultrastruct"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000206","article-title":"Classification, diagnosis, and differential diagnosis of multiple sclerosis","volume":"28","author":"Katz Sand I","year":"2015","unstructured":"Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015, 28:193-205. 10.1097\/WCO.0000000000000206","journal-title":"Curr Opin Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey","volume":"46","author":"Lublin FD","year":"1996","unstructured":"Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996, 46:907-11. 10.1212\/wnl.46.4.907","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/112.6.1419","article-title":"The natural history of multiple sclerosis: a geographically based study: 2 predictive value of the early clinical course","volume":"112","author":"Weinshenker BG","year":"1989","unstructured":"Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study: 2 predictive value of the early clinical course. Brain. 1989, 112:1419-28. 10.1093\/brain\/112.6.1419","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann H","year":"2012","unstructured":"Lassmann H, van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 2012, 8:647-56. 10.1038\/nrneurol.2012.168","journal-title":"Nat Rev Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis: new insights","volume":"97","author":"Cree BA","year":"2021","unstructured":"Cree BA, Arnold DL, Chataway J, et al.. Secondary progressive multiple sclerosis: new insights. Neurology. 2021, 97:378-88. 10.1212\/WNL.0000000000012323","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-018-0496-3","article-title":"Disease-modifying treatment in progressive multiple sclerosis","volume":"20","author":"Ciotti JR","year":"2018","unstructured":"Ciotti JR, Cross AH. Disease-modifying treatment in progressive multiple sclerosis. Curr Treat Options Neurol. 2018, 20:12. 10.1007\/s11940-018-0496-3","journal-title":"Curr Treat Options Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102124","article-title":"Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)","volume":"42","author":"Patti F","year":"2020","unstructured":"Patti F, Chisari CG, D'Amico E, et al.. Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study). Mult Scler Relat Disord. 2020, 42:102124. 10.1016\/j.msard.2020.102124","journal-title":"Mult Scler Relat Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231225929","article-title":"Recent trends in disease-modifying therapy use and associated sickness absence and disability pension among people with multiple sclerosis in Sweden","volume":"30","author":"Teni FS","year":"2024","unstructured":"Teni FS, Machado A, Fink K, Gyllensten H, Hillert J, Friberg E. Recent trends in disease-modifying therapy use and associated sickness absence and disability pension among people with multiple sclerosis in Sweden. Mult Scler. 2024, 30:419-31. 10.1177\/13524585231225929","journal-title":"Mult Scler"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.3324","article-title":"Association of pregnancy with the onset of clinically isolated syndrome","volume":"77","author":"Nguyen AL","year":"2020","unstructured":"Nguyen AL, Vodehnalova K, Kalincik T, et al.. Association of pregnancy with the onset of clinically isolated syndrome. JAMA Neurol. 2020, 77:1496-503. 10.1001\/jamaneurol.2020.3324","journal-title":"JAMA Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmhg.2004.10.005","article-title":"Multiple sclerosis: a short review of the disease and its differences between men and women","author":"Reipert B","year":"2004","unstructured":"Reipert B. Multiple sclerosis: a short review of the disease and its differences between men and women. J Men's Health Gender. 2004, 334-40. 10.1016\/j.jmhg.2004.10.005","journal-title":"J Men's Health Gender"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56020049","article-title":"Pregnancy and multiple sclerosis: an update on the disease modifying treatment strategy and a review of pregnancy\u2019s impact on disease activity","volume":"56","author":"Varyt\u0117 G","year":"2020","unstructured":"Varyt\u0117 G, Zakarevi\u010dien\u0117 J, Rama\u0161auskait\u0117 D, Lau\u017eikien\u0117 D, Arlauskien\u0117 A. Pregnancy and multiple sclerosis: an update on the disease modifying treatment strategy and a review of pregnancy\u2019s impact on disease activity. Medicina (Kaunas). 2020, 56:49. 10.3390\/medicina56020049","journal-title":"Medicina (Kaunas)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59030619","article-title":"Potential protective role of pregnancy and breastfeeding in delaying onset symptoms related to multiple sclerosis","volume":"59","author":"Logoteta A","year":"2023","unstructured":"Logoteta A, Piccioni MG, Nistri R, et al.. Potential protective role of pregnancy and breastfeeding in delaying onset symptoms related to multiple sclerosis. Medicina (Kaunas). 2023, 59:619. 10.3390\/medicina59030619","journal-title":"Medicina (Kaunas)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis","volume":"339","author":"Confavreux C","year":"1998","unstructured":"Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 1998, 339:285-91. 10.1056\/NEJM199807303390501","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1994.tb02728.x","article-title":"Effect of pregnancy on the prognosis for multiple sclerosis. A 5-year follow up investigation","volume":"90","author":"Stenager E","year":"1994","unstructured":"Stenager E, Stenager EN, Jensen K. Effect of pregnancy on the prognosis for multiple sclerosis. A 5-year follow up investigation. Acta Neurol Scand. 1994, 90:305-8. 10.1111\/j.1600-0404.1994.tb02728.x","journal-title":"Acta Neurol Scand"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102360","article-title":"Pregnancy and multiple sclerosis: clinical effects across the lifespan","volume":"18","author":"Nguyen AL","year":"2019","unstructured":"Nguyen AL, Eastaugh A, van der Walt A, Jokubaitis VG. Pregnancy and multiple sclerosis: clinical effects across the lifespan. Autoimmun Rev. 2019, 18:102360. 10.1016\/j.autrev.2019.102360","journal-title":"Autoimmun Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.59657\/2837-2565.brs.23.059","article-title":"A rare case of transverse myelitis during pregnancy, in a 23-year-old female in a resource-limited setup","volume":"3","author":"Moh\u2019d FS","year":"2023","unstructured":"Moh\u2019d FS, Magambo M, Kiritta R, et al.. A rare case of transverse myelitis during pregnancy, in a 23-year-old female in a resource-limited setup. BioRes Scientia. 2023, 3:1-5. 10.59657\/2837-2565.brs.23.059","journal-title":"BioRes Scientia"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12584-x","article-title":"MS treatment de-escalation: review and commentary","volume":"271","author":"Selmaj K","year":"2024","unstructured":"Selmaj K, Hartung HP, Mycko MP, Selmaj I, Cross AH. MS treatment de-escalation: review and commentary. J Neurol. 2024, 271:6426-38. 10.1007\/s00415-024-12584-x","journal-title":"J Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2012.09.008","article-title":"Transverse myelitis","volume":"31","author":"Beh SC","year":"2013","unstructured":"Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clin. 2013, 31:79-138. 10.1016\/j.ncl.2012.09.008","journal-title":"Neurol Clin"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.01.001","article-title":"Diagnosis and management of neuromyelitis optica spectrum disorders - an update","volume":"17","author":"Bruscolini A","year":"2018","unstructured":"Bruscolini A, Sacchetti M, La Cava M, et al.. Diagnosis and management of neuromyelitis optica spectrum disorders - an update. Autoimmun Rev. 2018, 17:195-200. 10.1016\/j.autrev.2018.01.001","journal-title":"Autoimmun Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-52","article-title":"Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance","volume":"7","author":"Jarius S","year":"2010","unstructured":"Jarius S, Franciotta D, Paul F, et al.. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation. 2010, 7:52. 10.1186\/1742-2094-7-52","journal-title":"J Neuroinflammation"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8596-7","article-title":"What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients","volume":"264","author":"Hamid SH","year":"2017","unstructured":"Hamid SH, Whittam D, Mutch K, et al.. What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients. J Neurol. 2017, 264:2088-94. 10.1007\/s00415-017-8596-7","journal-title":"J Neurol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00888","article-title":"Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis","volume":"9","author":"Borisow N","year":"2018","unstructured":"Borisow N, Mori M, Kuwabara S, Scheel M, Paul F. Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis. Front Neurol. 2018, 9:888. 10.3389\/fneur.2018.00888","journal-title":"Front Neurol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan S","year":"2016","unstructured":"Ramanathan S, Prelog K, Barnes EH, et al.. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 2016, 22:470-82. 10.1177\/1352458515593406","journal-title":"Mult Scler"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurad.2018.10.007","article-title":"Optic chiasm and oculomotor nerves involvement in active multiple sclerosis","volume":"47","author":"Carra-Dalliere C","year":"2020","unstructured":"Carra-Dalliere C, Menjot de Champfleur N, Ayrignac X, Labauge P. Optic chiasm and oculomotor nerves involvement in active multiple sclerosis. J Neuroradiol. 2020, 47:62-4. 10.1016\/j.neurad.2018.10.007","journal-title":"J Neuroradiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius S","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, et al.. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018, 15:134. 10.1186\/s12974-018-1144-2","journal-title":"J Neuroinflammation"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson AJ","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et al.. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018, 17:162-73. 10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle J","year":"2019","unstructured":"Kuhle J, Kropshofer H, Haering DA, et al.. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. 2019, 92:e1007-15. 10.1212\/WNL.0000000000007032","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000890","article-title":"MRI activity in MS and completed pregnancy: data from a tertiary academic center","volume":"7","author":"Houtchens M","year":"2020","unstructured":"Houtchens M, Bove R, Healy B, et al.. MRI activity in MS and completed pregnancy: data from a tertiary academic center. Neurol Neuroimmunol Neuroinflamm. 2020, 7:10.1212\/NXI.0000000000000890","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191550","article-title":"Specific absorption rate and specific energy dose: comparison of 1.5-T versus 3.0-T fetal MRI","volume":"295","author":"Barrera CA","year":"2020","unstructured":"Barrera CA, Francavilla ML, Serai SD, et al.. Specific absorption rate and specific energy dose: comparison of 1.5-T versus 3.0-T fetal MRI. Radiology. 2020, 295:664-74. 10.1148\/radiol.2020191550","journal-title":"Radiology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.28086","article-title":"Gadolinium retention in the brain of mother and pup mouse: effect of pregnancy and repeated administration of gadolinium-based contrast agents","volume":"56","author":"Yao X","year":"2022","unstructured":"Yao X, Zhang H, Shi D, et al.. Gadolinium retention in the brain of mother and pup mouse: effect of pregnancy and repeated administration of gadolinium-based contrast agents. J Magn Reson Imaging. 2022, 56:835-45. 10.1002\/jmri.28086","journal-title":"J Magn Reson Imaging"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12010009","article-title":"MRI in pregnancy and precision medicine: a review from literature","volume":"12","author":"Gatta G","year":"2021","unstructured":"Gatta G, Di Grezia G, Cuccurullo V, et al.. MRI in pregnancy and precision medicine: a review from literature. J Pers Med. 2021, 12:9. 10.3390\/jpm12010009","journal-title":"J Pers Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00421-0","article-title":"Multiple sclerosis in pregnancy: a commentary on disease modification and symptomatic drug therapies","volume":"12","author":"Iyer P","year":"2023","unstructured":"Iyer P, Dobson R. Multiple sclerosis in pregnancy: a commentary on disease modification and symptomatic drug therapies. Neurol Ther. 2023, 12:1-10. 10.1007\/s40120-022-00421-0","journal-title":"Neurol Ther"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v3.i7.545","article-title":"Treatment strategies for multiple sclerosis: when to start, when to change, when to stop?","volume":"3","author":"Gajofatto A","year":"2015","unstructured":"Gajofatto A, Benedetti MD. Treatment strategies for multiple sclerosis: when to start, when to change, when to stop?. World J Clin Cases. 2015, 3:545-55. 10.12998\/wjcc.v3.i7.545","journal-title":"World J Clin Cases"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/297627-new-onset-multiple-sclerosis-in-pregnancy-diagnostic-approaches-and-treatment-dilemmas","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T18:58:08Z","timestamp":1732820288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/297627-new-onset-multiple-sclerosis-in-pregnancy-diagnostic-approaches-and-treatment-dilemmas"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.74685","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,28]]}}}